PLUS THERAPEUTICS, INC. Common Stock Shares Outstanding

• PLUS THERAPEUTICS, INC. showed an increase of +2,251.9% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from PLUS THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
• XBRL data for this metric is available from 2010 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2011: 52.47 million shares | Q3 2011: 54.83 million shares | Q1 2012: 58.43 million shares | Q2 2012: 58.71 million shares | Q3 2012: 56.59 million shares | Q1 2013: 67.17 million shares | Q2 2013: 67.24 million shares | Q3 2013: 67.27 million shares | Q1 2014: 75.46 million shares | Q2 2014: 79.54 million shares | Q3 2014: 83.57 million shares | Q1 2015: 114.10 million shares | Q2 2015: 150.96 million shares | Q3 2015: 158.47 million shares | Q1 2016: 200.00 million shares | Q2 2016: 6.70 million shares | Q2 2016: 20.49 million shares | Q3 2016: 20.50 million shares | Q1 2017: 23.77 million shares | Q2 2017: 33.33 million shares | Q3 2017: 34.72 million shares | Q1 2018: 61.61 million shares | Q2 2018: 6.18 million shares | Q3 2018: 11.69 million shares | Q1 2019: 14.83 million shares | Q2 2019: 296,609 shares | Q3 2019: 50.00 million shares | Q3 2019: 2.84 million shares | Q1 2020: 3.88 million shares | Q2 2020: 4.27 million shares | Q3 2020: 4.59 million shares | Q1 2021: 10.18 million shares | Q2 2021: 12.09 million shares | Q3 2021: 15.36 million shares | Q1 2022: 22.20 million shares | Q2 2022: 22.47 million shares | Q3 2022: 32.57 million shares | Q1 2023: 36.12 million shares | Q2 2023: 37.40 million shares | Q2 2023: 2.88 million shares | Q3 2023: 4.52 million shares | Q1 2024: 4.26 million shares | Q2 2024: 5.70 million shares | Q3 2024: 5.90 million shares | Q1 2025: 17.00 million shares | Q2 2025: 92.18 million shares | Q3 2025: 131.61 million shares.
• Over the full 19 years of available data (2010 to 2025), PLUS THERAPEUTICS, INC.'s Common Stock Shares Outstanding has grown by 166.9%.
• Historical annual values: Fiscal year 2025: 138.68 million shares | Fiscal year 2024: 5.90 million shares | Fiscal year 2023: 4.44 million shares | Fiscal year 2023: 37.40 million shares | Fiscal year 2022: 2.24 million shares | Fiscal year 2021: 15.51 million shares | Fiscal year 2020: 6.75 million shares | Fiscal year 2019: 3.88 million shares | Fiscal year 2018: 296,609 shares | Fiscal year 2018: 6.20 million shares | Fiscal year 2017: 5.78 million shares | Fiscal year 2016: 21.71 million shares | Fiscal year 2016: 13.30 million shares | Fiscal year 2015: 13.00 million shares | Fiscal year 2014: 99.35 million shares | Fiscal year 2013: 71.31 million shares | Fiscal year 2012: 65.91 million shares | Fiscal year 2011: 56.59 million shares | Fiscal year 2010: 51.96 million shares.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026